Search
healthcare › clinical-trials › h-56035
… This phase II/III trial compares the addition of nivolumab to the usual treatment of … treat patients with advanced stomach or esophageal cancer. For more information: https://clinicaltrials.gov/study/NCT06203600 … PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer …
research › ... › lab-news
… Feb. 26, 2024: … website … purposes. Read more about the project on the ALSF website and blog . …
healthcare › ... › breast-cancer-treatment-options
… at the Smith Breast Center are at the forefront of the latest technologies and treatments. They conduct research …
healthcare › ... › nontuberculous-mycobacterial-ntm-infection-program
… pulmonary function testing and imaging with your initial visit. Sputum testing CT imaging Blood testing EKG … plan for you, and have a productive initial clinical visit. As appropriate, this records review will include the following: Office notes of visits with your primary care physician and other …
education › school-of-medicine › graduate-medical-education
… medical city in the world, averages 8 million patients visits per year and 9,200 total patient beds. … Visit the following links to view resources provided to our …
research › baylor-research › research-resources
… extensive research (link to research) resources, including 26 advanced technology core labs and numerous collaborative …
departments › ... › grant-approvals
… an electronic IRB form, please log on to the Baylor BRAIN website, select eSP1. For help with email …
healthcare › clinical-trials › h-44098
… Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease. … of the study drug oral ozanimod as a treatment for moderately to severely active Crohn’s Disease (CD). … . You may qualify for this study if: You are a male or female between the ages …
healthcare › clinical-trials › h-42481
… The purpose of this study is to compare the usual approach (no more treatment, additional … Testing Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple-Negative Breast Cancer …
about-us › ... › organ-donation-policy
… someone is added to the national transplant waiting list. Unfortunately, nearly half of all listed candidates will die waiting for a transplant. Research suggests there are … (OPOs). Baylor College of Medicine supports these efforts – firmly believing that more accountability is needed …